KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Revenue (2018 - 2025)

Historic Revenue for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $240000.0.

  • Vir Biotechnology's Revenue fell 8991.6% to $240000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 7855.45%. This contributed to the annual value of $74.2 million for FY2024, which is 1389.53% down from last year.
  • Vir Biotechnology's Revenue amounted to $240000.0 in Q3 2025, which was down 8991.6% from $1.2 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Revenue high stood at $1.2 billion for Q1 2022, and its period low was $240000.0 during Q3 2025.
  • For the 5-year period, Vir Biotechnology's Revenue averaged around $155.2 million, with its median value being $16.8 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first surged by 6227140.69% in 2022, then tumbled by 9929.54% in 2023.
  • Quarter analysis of 5 years shows Vir Biotechnology's Revenue stood at $812.7 million in 2021, then crashed by 93.92% to $49.4 million in 2022, then crashed by 66.03% to $16.8 million in 2023, then fell by 26.29% to $12.4 million in 2024, then plummeted by 98.06% to $240000.0 in 2025.
  • Its last three reported values are $240000.0 in Q3 2025, $1.2 million for Q2 2025, and $3.0 million during Q1 2025.